The Complainant is a global pharmaceutical company which delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. The Complainant is one of the world’s largest generic medicines producers, leveraging a portfolio of 3,600 different products in nearly every therapeutic area. According to the Complainant’s annual report, the Complainant was active in 2024 in 57 countries, and it had revenues of more than USD 16.5 billion, and approximately 37,000 employees internationally.<\/p>\n
The Complainant uses the domain name <tevabiosimilars.com> (registered on December 15, 2009), for an official website which displays information about the Complainant and its activities.<\/p>\n
The disputed domain name <tevabiosmilars.com> was registered on June 19, 2025, and resolves to the Complainant’s said official website. MX records are configured in the DNS to which the disputed domain name has been delegated, meaning that it is capable of receiving e-mail.<\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "
Complainant:<\/p>\n
The disputed domain name reproduces the Complainant’s distinctive TEVA trademark in its entirety and is almost identical to the Complainant’s TEVA BIOSIMILAIRES trademark, and also to the Complainant’s official domain name <tevabiosimilars.com>, except for the deletion of one of its letters, “i”. The disputed domain name is a typical typosquatting <\/em>example, as it reproduces the Complainant’s trademark and domain name in their entirety but with only minor alterations of letters, which do not prevent the Complainant’s trademark from being sufficiently recognizable within the disputed domain name.<\/p>\n The disputed domain name contains the Complainant’s TEVA mark together with the combination of letters “biosmilars”, and the suffix “.com”, which may be disregarded for the purposes of the comparison as is typical in proceedings under the Policy. The disputed domain name is therefore identical or confusingly similar to a mark in which the Complainant has rights.<\/p>\n The Respondent has no rights or legitimate interests in the disputed domain name.<\/p>\n The Respondent is not a licensee of the Complainant, and it has not received any consent, permission, or authorization from the Complainant to use its well-known TEVA mark in association with the registration of the disputed domain name. The disputed domain name and the terms “tevabiosmilars” or “teva biosmilars” have no meaning in English. The Complainant has found nothing to suggest that the Respondent owns any identical trademarks to the disputed domain name or to the terms “tevabiosmilars” or “teva biosmilars”, or has been commonly known by such terms.<\/p>\n The disputed domain name is a typosquatted version of the Complainant’s trademark and was registered in an attempt to take advantage of Internet users’ typographical errors. This can constitute evidence that a respondent lacks rights and legitimate interests in the domain name concerned.<\/p>\n The disputed domain name redirects to the Complainant’s official website. Accordingly, the Respondent is not making a bona fide<\/em> offering of goods or services by means of the disputed domain name, nor a legitimate non-commercial or fair use thereof.<\/p>\n The disputed domain name was registered and is being used in bad faith.<\/p>\n The Complainant’s trademark is widely known and previous panels under the Policy have confirmed its notoriety. Given the distinctiveness of the Complainant's trademark and reputation, it is reasonable to infer that the Respondent has registered the disputed domain name with full knowledge of the Complainant's trademark. The misspelling of the Complainant’s trademark was intentionally designed to be confusingly similar thereto. Previous panels under the Policy have seen this as evidence of bad faith.<\/p>\n The disputed domain name redirects to the Complainant’s official website, confirming the Respondent’s prior knowledge of the Complainant’s rights, which is a hallmark of bad faith. The disputed domain name has been registered by the Respondent in an effort to take advantage of the reputation that the Complainant has built up in its trademark with the sole aim of creating a likelihood of confusion with the Complainant’s trademarks and official domain name.<\/p>\n The disputed domain name has configured MX records which suggests that the disputed domain name may be used actively for e-mail purposes, which constitutes a threat of abusive use of the disputed domain name, such as use in a phishing scheme. It is inconceivable that the Respondent will be able to make any good faith use of the disputed domain name as part of an e-mail address.<\/p>\n Respondent:<\/p>\n No administratively compliant Response has been filed.<\/p>",
"rights": " The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
"no_rights_or_legitimate_interests": " The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
"bad_faith": " The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
"procedural_factors": " The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
"decision": "Accepted",
"panelists": [
"Andrew Lothian"
],
"date_of_panel_decision": "2025-07-21 00:00:00",
"informal_english_translation": " The Complainant is the registered owner of multiple trademarks consisting of or containing TEVA including:<\/p>\n United States of America Registered Trademark Number 1567918 for the word mark TEVA, registered on November 28, 1989, in Class 5;<\/p>\n European Union Registered Trademark Number 7257611 for the figurative mark TEVA, registered on August 4, 2009, in Classes 1, 3, 5, 10, 31, and 42; and<\/p>\n French Registered Trademark Number 3706086 for the word mark TEVA BIOSIMILAIRES, registered on January 20, 2010, in Classes 1, 5, 35, 41, 42 and 44.<\/p>",
"decision_domains": {
"tevabiosmilars.com": "TRANSFERRED"
},
"panelist": null,
"panellists_text": null
}